This report outlines how Europe’s consumer market for cannabis is increasingly dominated by herbal products, and how imported cannabis resin appears to be getting stronger.
This report provides a top-level overview of the long-term drug-related trends and developments at European level, while homing in on emerging problems in specific countries.
This report shows how some medications can reduce specific symptoms (e.g. cravings), yet no single pharmacological solution has been found for cocaine dependence overall.
For service users, the opportunity to have ‘a voice’ began to disrupt the routine objectification or dehumanisation that consistently, if unintentionally, characterise the treatment experience.
This practical toolkit is designed to young people who are passionate about advancing HIV and sexual and reproductive health and rights through national advocacy in the post-2015 agenda.
This report provides an analysis of the global synthetic drugs market and includes both Amphetamine-Type Stimulants (ATS) and New Psychoactive Substances (NPS).
These briefings offer evidence of the ineffectiveness of the traditional “war on drugs” approach to reduce the supply or demand for drugs in consumer markets, and provide policy guidance and examples of best practice on new drug law strategies.
